223 related articles for article (PubMed ID: 9391045)
1. The major chromatin protein histone H1 binds preferentially to cis-platinum-damaged DNA.
Yaneva J; Leuba SH; van Holde K; Zlatanova J
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13448-51. PubMed ID: 9391045
[TBL] [Abstract][Full Text] [Related]
2. Interaction of histone H1 with cis-platinum modified DNA.
Paneva EG; Spassovska NC; Grancharov KC; Zlatanova JS; Yaneva JN
Z Naturforsch C J Biosci; 1998; 53(1-2):135-8. PubMed ID: 9528130
[TBL] [Abstract][Full Text] [Related]
3. DNA adducts of cis-diamminedichloroplatinum(II) and its trans isomer inhibit RNA polymerase II differentially in vivo.
Mello JA; Lippard SJ; Essigmann JM
Biochemistry; 1995 Nov; 34(45):14783-91. PubMed ID: 7578087
[TBL] [Abstract][Full Text] [Related]
4. Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins.
Kaspárková J; Brabec V
Biochemistry; 1995 Sep; 34(38):12379-87. PubMed ID: 7547982
[TBL] [Abstract][Full Text] [Related]
5. The binding affinity of HMG1 protein to DNA modified by cis-platin and its analogs correlates with their antitumor activity.
Pasheva EA; Ugrinova I; Spassovska NC; Pashev IG
Int J Biochem Cell Biol; 2002 Jan; 34(1):87-92. PubMed ID: 11733188
[TBL] [Abstract][Full Text] [Related]
6. Proteins that specifically recognize cisplatin-damaged DNA: a clue to anticancer activity of cisplatin.
Zlatanova J; Yaneva J; Leuba SH
FASEB J; 1998 Jul; 12(10):791-9. PubMed ID: 9657519
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel protein that specifically binds to DNA modified by N-acetoxy-acetylaminofluorene and cis-diamminedichloroplatinum.
Pietrowska M; Widłak P
Acta Biochim Pol; 2005; 52(4):867-74. PubMed ID: 15940347
[TBL] [Abstract][Full Text] [Related]
8. HMG1 protein inhibits the translesion synthesis of the major DNA cisplatin adduct by cell extracts.
Hoffmann JS; Locker D; Villani G; Leng M
J Mol Biol; 1997 Jul; 270(4):539-43. PubMed ID: 9245584
[TBL] [Abstract][Full Text] [Related]
9. A single HMG domain in high-mobility group 1 protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct.
Chow CS; Barnes CM; Lippard SJ
Biochemistry; 1995 Mar; 34(9):2956-64. PubMed ID: 7893709
[TBL] [Abstract][Full Text] [Related]
10. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.
Trimmer EE; Zamble DB; Lippard SJ; Essigmann JM
Biochemistry; 1998 Jan; 37(1):352-62. PubMed ID: 9425057
[TBL] [Abstract][Full Text] [Related]
11. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
Ohndorf UM; Rould MA; He Q; Pabo CO; Lippard SJ
Nature; 1999 Jun; 399(6737):708-12. PubMed ID: 10385126
[TBL] [Abstract][Full Text] [Related]
12. The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin.
Mello JA; Acharya S; Fishel R; Essigmann JM
Chem Biol; 1996 Jul; 3(7):579-89. PubMed ID: 8807890
[TBL] [Abstract][Full Text] [Related]
13. Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent.
Burstyn JN; Heiger-Bernays WJ; Cohen SM; Lippard SJ
Nucleic Acids Res; 2000 Nov; 28(21):4237-43. PubMed ID: 11058123
[TBL] [Abstract][Full Text] [Related]
14. Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts.
Roberts JJ; Friedlos F
Cancer Res; 1987 Jan; 47(1):31-6. PubMed ID: 3791217
[TBL] [Abstract][Full Text] [Related]
15. Histone H1 interacts preferentially with DNA fragments containing a cisplatin-induced 1,2-intrastrand cross-link.
Yaneva JN; Paneva EG; Zacharieva SI; Zlatanova J
Z Naturforsch C J Biosci; 2007; 62(11-12):905-8. PubMed ID: 18274296
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin reacts with histone H1 and the adduct forms a ternary complex with DNA.
Cheng L; Li C; Xi Z; Wei K; Yuan S; Arnesano F; Natile G; Liu Y
Metallomics; 2019 Mar; 11(3):556-564. PubMed ID: 30672544
[TBL] [Abstract][Full Text] [Related]
17. Recognition and repair of DNA-cisplatin adducts.
Woźniak K; Błasiak J
Acta Biochim Pol; 2002; 49(3):583-96. PubMed ID: 12422229
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin: from DNA damage to cancer chemotherapy.
Cohen SM; Lippard SJ
Prog Nucleic Acid Res Mol Biol; 2001; 67():93-130. PubMed ID: 11525387
[TBL] [Abstract][Full Text] [Related]
19. Effects of a piperidine ligand on DNA modification by antitumor cisplatin analogues.
Kasparkova J; Novakova O; Najajreh Y; Gibson D; Perez JM; Brabec V
Chem Res Toxicol; 2003 Nov; 16(11):1424-32. PubMed ID: 14615968
[TBL] [Abstract][Full Text] [Related]
20. Reaction of Histone H1 with trans-Platinum Complexes and the Effect on DNA Platination.
Cheng L; Li C; Yuan S; Shi H; Zhao L; Zhang L; Arnesano F; Natile G; Liu Y
Inorg Chem; 2019 May; 58(9):6485-6494. PubMed ID: 31021622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
